Geode Capital Management’s NextCure NXTC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$106K Sell
19,142
-540
-3% -$2.98K ﹤0.01% 4045
2025
Q1
$113K Buy
19,682
+189
+1% +$1.09K ﹤0.01% 4002
2024
Q4
$180K Buy
19,493
+848
+5% +$7.85K ﹤0.01% 3936
2024
Q3
$307K Buy
18,645
+2,318
+14% +$38.1K ﹤0.01% 3760
2024
Q2
$312K Buy
16,327
+1,768
+12% +$33.7K ﹤0.01% 3750
2024
Q1
$390K Hold
14,559
﹤0.01% 3697
2023
Q4
$199K Hold
14,559
﹤0.01% 3945
2023
Q3
$225K Buy
14,559
+1,427
+11% +$22.1K ﹤0.01% 3933
2023
Q2
$284K Sell
13,132
-910
-6% -$19.7K ﹤0.01% 3889
2023
Q1
$249K Hold
14,042
﹤0.01% 3939
2022
Q4
$237K Sell
14,042
-27
-0.2% -$456 ﹤0.01% 4005
2022
Q3
$464K Sell
14,069
-182
-1% -$6K ﹤0.01% 3760
2022
Q2
$803K Buy
14,251
+1,600
+13% +$90.2K ﹤0.01% 3520
2022
Q1
$737K Buy
12,651
+734
+6% +$42.8K ﹤0.01% 3757
2021
Q4
$858K Buy
11,917
+204
+2% +$14.7K ﹤0.01% 3782
2021
Q3
$947K Buy
11,713
+436
+4% +$35.3K ﹤0.01% 3710
2021
Q2
$1.09M Sell
11,277
-9,584
-46% -$923K ﹤0.01% 3553
2021
Q1
$2.51M Buy
20,861
+5,294
+34% +$636K ﹤0.01% 3146
2020
Q4
$2.04M Sell
15,567
-1,211
-7% -$158K ﹤0.01% 3076
2020
Q3
$1.77M Sell
16,778
-275
-2% -$29K ﹤0.01% 2938
2020
Q2
$4.39M Buy
17,053
+1,782
+12% +$458K ﹤0.01% 2411
2020
Q1
$6.79M Buy
15,271
+1,648
+12% +$733K ﹤0.01% 1965
2019
Q4
$9.21M Buy
13,623
+8,609
+172% +$5.82M ﹤0.01% 2071
2019
Q3
$1.86M Sell
5,014
-441
-8% -$163K ﹤0.01% 2978
2019
Q2
$980K Buy
+5,455
New +$980K ﹤0.01% 3245